🇺🇸 FDA
Patent

US 11020495

Humanized low affinity FCγR mouse cells

granted A61KA61K49/0008

Quick answer

US patent 11020495 (Humanized low affinity FCγR mouse cells) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K49/0008